In parallel, natriuretic peptides, particularly NT-proBNP, and cardiac troponins, such as high-sensitivity cardiac troponin I (hs-cTnI), are commonly employed for risk stratification and diagnosis in HF, yet their utility in capturing the complexity of CRS is limited. This evidence concerns the gene TNNI3 and hydrops fetalis.